Lipoprotein(a) reduction with inclisiran, alirocumab, evolocumab, enlicitide, and lerodalcibep: A systematic review and meta-analysis of randomized controlled trials

Journal of clinical lipidology 2026

View at publisher

Authors: Martin Mulligan, Rahul S. Gandhi, Rishabh Vishwakarma, Romit Bhattacharya

DOI: 10.1016/j.jacl.2026.03.019

Cited by: 4

References: 71

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Diabetes Cardiovascular Risks and Lipoproteins Cancer Lipids and Metabolism

References 71